Real-world effectiveness of Semaglutide treatment on weight loss maintenance after weight loss in patients with obesity or overweight and diabetes
Semaglutide induces WL maintenance after 12 and 24 months of treatment. Our results show a comparable effectiveness of IS and OS in T2DM patients with obesity or overweight. IS and OS treatment provide significant WL that allows reaching the glycometabolic therapeutic goal in a short time. Level of Evidence Level II.
Authors
- Olga Disoteo (ORCID: https://orcid.org/0000-0002-9369-2629)
- Lidia Gavazzi
- F Muratori (ORCID: https://orcid.org/0000-0002-5153-8033)
- Federico Vignati
- Michela Del Prete (ORCID: https://orcid.org/0000-0003-3702-8931)
- G. Di Sacco
Institutions
- Azienda Socio Sanitaria Territoriale Lariana (IT)
- Ospedale Sant'Anna (IT)
Publication Details
- Journal
- Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1007/s40519-024-01711-2
- Citations
- 3
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.18